Gasior Mariusz, Gierlotka Marek, Pres Damian, Lekston Andrzej, Zebik Tadeusz, Hawranek Michał, Tajstra Mateusz, Stasik-Pres Gabriela, Kalarus Zbigniew, Poloński Lech
3rd Department and Division of Cardiology, Silesian Medical University, Silesian Centre for Heart Diseases, Zabrze, Poland.
Kardiol Pol. 2007 May;65(5):503-12; discussion 513-4.
Results of studies comparing direct stenting (DS) with conventional stenting (CS) after balloon predilatation in patients with acute myocardial infarction (MI) have been reported in the past, however they are conflicting. There are only few randomised studies that aim to answer whether DS improves epicardial and myocardial patency.
To assess the effects of DS on epicardial and myocardial patency in patients with acute MI.
Consecutive patients with acute MI were randomised either to DS or CS strategy. Clinical exclusion criteria were as follows: clinical and electrocardiographic features of reperfusion, pulmonary oedema, cardiogenic shock, contradictions to coronarography, allergy to aspirin, ticlopidine, clopidogrel, heparin and stainless steel. Angiographic exclusion criteria were as follows: lesion <50% with correct patency in the infarct-related artery (IRA), lesion in the left main coronary artery, previously performed percutaneous coronary intervention in the target vessel, diameter of the IRA <2 mm or >4 mm. We assessed epicardial patency according to the TIMI (thrombolysis in myocardial infarction) scale and myocardial patency according to the TMPG (TIMI myocardial perfusion grade) scale. In addition, we analysed ST segment resolution in 12-lead electrocardiography (ECG). The ECG was performed before and 30 minutes after PCI.
We analysed 300 consecutive patients with acute ST segment elevation MI. After exclusion of patients not suitable for the study design, the DS group comprised 110 patients and the CS group - 107 patients. Clinical and angiographic results were similar in both groups. Initial TIMI 0 (48.2% vs. 43.0%), initial TIMI 3 (31.8% vs. 28.0%), initial TMPG 0-1 (77.3% vs. 78.5%), final TIMI 3 (95.5% vs. 93.5%) and final TMPG 2-3 (68.2% vs. 60.8%) were similar in the DS and CS groups, respectively (p=NS). The incidence of no-reflow phenomenon was comparable in both groups (4.5% vs. 6.5%, NS). The inclusive rate of no-reflow phenomenon plus worsening patency in the IRA were 6.4% vs. 10.3% in the DS and CS groups respectively. The ST segment resolution > or = 50% was 58.1% in the DS group and 56.1% in the CS group (NS).
Direct stenting does not significantly improve epicardial and myocardial patency in an unselected group of patients with acute ST segment elevation MI.
过去已有关于急性心肌梗死(MI)患者在球囊预扩张后直接支架置入术(DS)与传统支架置入术(CS)对比研究的结果报道,但结果相互矛盾。仅有少数随机研究旨在回答DS是否能改善心外膜和心肌通畅情况。
评估DS对急性MI患者心外膜和心肌通畅情况的影响。
将连续的急性MI患者随机分为DS组或CS组。临床排除标准如下:再灌注的临床和心电图特征、肺水肿、心源性休克、冠状动脉造影禁忌证、对阿司匹林、噻氯匹定、氯吡格雷、肝素和不锈钢过敏。血管造影排除标准如下:梗死相关动脉(IRA)病变<50%且通畅正常、左主干冠状动脉病变、目标血管先前已行经皮冠状动脉介入治疗、IRA直径<2mm或>4mm。我们根据心肌梗死溶栓(TIMI)分级评估心外膜通畅情况,根据TIMI心肌灌注分级(TMPG)评估心肌通畅情况。此外,我们分析了12导联心电图(ECG)中的ST段回落情况。ECG在PCI术前及术后30分钟进行。
我们分析了300例连续的急性ST段抬高型MI患者。排除不适合该研究设计的患者后,DS组有110例患者,CS组有107例患者。两组的临床和血管造影结果相似。DS组和CS组的初始TIMI 0级(48.2%对43.0%)、初始TIMI 3级(31.8%对28.0%)、初始TMPG 0 - 1级(77.3%对78.5%)、最终TIMI 3级(95.5%对93.5%)和最终TMPG 2 - 3级(68.2%对60.8%)分别相似(p = 无显著性差异)。两组无复流现象发生率相当(4.5%对6.5%,无显著性差异)。DS组和CS组无复流现象加IRA通畅情况恶化的发生率分别为6.4%对10.3%。DS组ST段回落≥50%的比例为58.1%,CS组为56.1%(无显著性差异)。
在未选择的急性ST段抬高型MI患者群体中,直接支架置入术并不能显著改善心外膜和心肌通畅情况。